Oxygen supplementation and hyperoxia in critically ill cardiac patients: from pathophysiology to clinical practice

A Thomas, S van Diepen, R Beekman, SS Sinha… - JACC: Advances, 2022 - jacc.org
Oxygen supplementation has been a mainstay in the management of patients with acute
cardiac disease. Although hypoxia is known to be detrimental, the adverse effects of …

Oxygen therapy in pulmonary vascular disease: a systematic review, meta-analysis, and comment

M Schuster, J Müller, EI Schwarz… - Heart Failure …, 2023 - heartfailure.theclinics.com
Oxygen Therapy in Pulmonary Vascular Disease - Heart Failure Clinics Skip to Main
Content Advertisement Heart Failure Clinics Log in Register Log in Subscribe Claim Skip …

[HTML][HTML] The impact of breathing hypoxic gas and oxygen on pulmonary hemodynamics in patients with pulmonary hypertension

AF Carta, M Lichtblau, C Berlier, S Saxer… - Frontiers in …, 2022 - frontiersin.org
Background Pure oxygen breathing (hyperoxia) may improve hemodynamics in patients
with pulmonary hypertension (PH) and allows to calculate right-to-left shunt fraction (Qs/Qt) …

Oxygen therapy lowers right ventricular afterload in experimental acute pulmonary embolism

MD Lyhne, JV Hansen, SJ Dragsbaek… - Critical Care …, 2021 - journals.lww.com
OBJECTIVES: To investigate if oxygen could unload the right ventricle and improve right
ventricle function in a porcine model mimicking intermediate-high risk acute pulmonary …

Low-frequency ultrasound for pulmonary hypertension therapy

V Ostasevicius, V Jurenas, M Venslauskas… - Respiratory …, 2024 - Springer
Background Currently, there are no reliable clinical tools that allow non-invasive therapeutic
support for patients with pulmonary arterial hypertension. This study aims to propose a low …

Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension

C Pelaia, G Armentaro, C Lupia, A Maiorano… - Journal of Clinical …, 2023 - mdpi.com
High-flow nasal cannula (HFNC) has several benefits in patients affected by different forms
of acute respiratory failure, based on its own mechanisms. We postulated that HFNC may …

Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies

J Tsai, S Malik, SC Tjen-A-Looi - 2024 - preprints.org
Pulmonary hypertension (PH) is a severe and chronic disease characterized by increased
pulmonary vascular resistance and remodeling often precipitating right-sided heart …

The Utility of Echocardiography in Patients with Pulmonary Hypertension Secondary to Idiopathic bronchiectasis

JW Bai, B Mao, YH Gao, L Wang, Z Cao, JX Li, HW Lu… - 2024 - researchsquare.com
Background Pulmonary hypertension (PH) is a critical complication in bronchiectasis.
However, the optimal noninvasive test for evaluating PH in bronchiectasis patients remains …

Oxigenación cerebral y etilefrina para hipotensión arterial por inducción anestésica estudio observacional

JD PULECIO SOLER - 2024 - repositorio.ucaldas.edu.co
Objective: to describe the behavior of cerebral oxygenation measured by near-infrared
spectroscopy during arterial hypotension secondary to intravenous anesthetic induction, and …

Editors' presentation: focus on pharmacological interventions

G Halasz, MF Piepoli - European Journal of Preventive …, 2021 - academic.oup.com
Type 2 diabetes mellitus (T2DM) is commonly complicated by atherosclerotic cardiovascular
disease (ASCVD) and is also associated with an increased risk of hospitalization for heart …